Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 20.78
-0.12 (-0.57%)
Feb 13, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 8.26 billion as of February 13, 2026. Its market cap has decreased by -1.58% in one year.
Market Cap
8.26B
Enterprise Value
6.40B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.78
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 8.26B, a decrease of -75.79%. That is a compound annual growth rate of -28.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.26B | 3.80% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 9.28B |
| Sino Biological,Inc. | 8.91B |
| Daan Gene | 8.84B |
| Jiangxi Fushine Pharmaceutical | 8.82B |
| Shanghai Medicilon | 8.74B |
| Anhui Huaheng Biotechnology | 8.55B |
| Acrobiosystems | 8.35B |
| Zhejiang Ausun Pharmaceutical | 7.95B |